Clinicians should use caution when prescribing this medication in patients with heart disease because of risk of severe adverse effects and even death. Test your skills in this FDA quiz.
FDA Approves Expanded Indication for Cerliponase Alfa to Treat CLN2 Disease in Children Under 3 Years
Episode 116: Understanding Vorasidenib's Therapeutic Benefit on Neurocognition, Seizure Control in Diffuse Gliomas
Endo Voluntarily Recalls One Lot of Clonazepam Tablets Following Mislabeling Error
Special Episode: FDA Approves Diazepam Buccal Film for Pediatric Seizures
NeurologyLive® Brain Games: July 21, 2024
NeurologyLive® Friday 5 — July 19, 2024